Eli Lilly & Co. (LLY) Tops Q2 EPS by 1c; Raises, Narrows FY11 EPS
Eli Lilly & Co. (NYSE: LLY) reported Q2 EPS of $1.18, $0.01 better than the analyst estimate of $1.17. Revenue for the quarter came in at $6.25 billion versus the consensus estimate of $5.99 billion.
Eli Lilly & Co. sees FY2011 EPS of $4.25-$4.35, versus the consensus of $4.28.
Eli Lilly & Co. sees FY2011 EPS of $4.25-$4.35, versus the consensus of $4.28.